Site menu

Search by ticker code:
Generic filters

Menu

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

NIB (ASX:NHF) share price up after healthy HY21 profit growth

The NIB Holdings Limited (ASX: NHF) share price has gone up after the private health insurer announced its FY21 half-year result.

What numbers did NIB announce?

NIB said that total revenue was down 1.1% to $1.3 billion, but the group claims expense grew by 0.9% to $1 billion.

However, the group expenses fell by 14.1% to $172.1 million. This helped group underlying operating profit rise by 4.4% to $86.9 million. Net profit after tax (NPAT) rose by 15.9% to $66.2 million.

Despite all of the negative impacts on NIB because of COVID-19, the company was able to deliver growth. Remember that NIB has divisions which focus on international workers, students and travel insurance – so these areas have been very disrupted.

However, its membership of Australian resident health insurance (ARHI) increased by 2.7%, or 16,000 members. It also grew its premium income by 2.2% to $1.1 billion. The premium revenue growth would have been 4.2% if not for the six month postponement of the 2020 annual premium increase.

NIB said that ARHI profitability has been slightly distorted by COVID-19 and consequential delays in treatment and claims. ARHI’s underlying operating profit was up 42.2% to $89 million.

NIB also disclosed that of the growth, about 52% of policy sales were to members under the age of 40 with more than 45% of all sales new to private health insurance. There was also an increase in NIB’s member retention.

The private health insurer said that the above growth counters all the negative talk about the value of private health insurance and COVID-19 has clearly raised people’s awareness about the risk of disease and the need for protection.

NIB dividend

The NIB board announced a dividend, it’s 10 cents per share, the same as the prior corresponding period.

Management comments

NIB CEO and Managing Director Mark Fitzgibbon said: “ARHI has been slightly distorted by COVID-19 and consequential delays in treatment and claims which is still playing out.”

Talking about the travel insurance business, he said that: “It’s all a bit gloomy at the moment yet COVID-19 will pass and our travel business is well positioned for recovery and growth when travel restrictions are relaxed or borders re-open. The hiatus is actually providing us with an opportunity to recalibrate and modernise the business.”

Summary thoughts

It was nice to see that the business committed that NIB operations would be carbon neutral by the end of FY22.

It wasn’t yet able to provide earnings guidance for FY21 due to COVID-19. It was a solid result and I think NIB could be the pick of the insurance industry. Though I’m not really a fan of many insurance businesses, so that’s not saying too much.

Before you consider NIB, I suggest getting a free Rask account and accessing our full stock reports. Click this link to join for free and access our analyst reports.

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

At the time of publishing, the author of this article does not have a financial or commercial interest in any of the companies mentioned.
Skip to content